Doxycycline hyclate, latrunculin A, D-luciferin, DAPT and DBZ were from Sigma; fibronectin was from Santa Cruz Biotechnology; cytochalasin D was from Calbiochem; CPRG was from Roche. For the inducible expression of YAP constructs, cDNA for human YAP1 5SA (LATS-mutant sites)21 (link) and human YAP1 5SA/S94A (TEAD-binding mutant)34 (link) were made insensitive to YAP siRNA #1 and subcloned, together with an HA-tag, in FUW-tetO-MCS, obtained by substituting the Oct4 sequence in FUW-tetO-hOct4 (Addgene #20726)65 (link) with a new multiple cloning site (MCS). This generated FUW-tetO-HA-YAP5SA and FUW-tetO-HA-YAP5SA/S94A were used throughout this study. FUW-tetO-MCS (empty vector) or FUW-tetO-RFP plasmids, obtained by subcloning the RFP coding sequence from the pTomo vector (Addgene #26291), were used as controls. FUdeltaGW-rtTA was from Addgene (#19780)66 (link). FUW-tetO-N1ICD-Myc and FUW-tetO-GFP-DNMAML1 were obtained by subloning in the FUW-tetO-MCS the corresponding coding sequences, respectively, from pcDNA3 N1ICD-Myc67 (link) and MigRI-DNMAML1-GFP38 (link). All constructs were confirmed by sequencing. The 8xGTIIC-lux (Addgene #34615) was previously described22 (link). The 3D.A-Lux was gently provided by Guido Posern68 (link). Primers for RT–PCR are listed in Supplementary Data 3.
Free full text: Click here